TABLE 3.

Clinical data reported for cases in which ETEC was identified as the sole pathogen and expressed CFA/I, CS5 plus CS6, CS6, and CS14

Clinical dataNo. (%) of cases by CF type
CFA/I (n = 38)CS5 + CS6 (n = 16)CS6 (n = 17)CS14 (n = 15)Othersa (n = 25)CF negativeb (n = 110)All ETEC (n = 221)
Hospitalization7 (18)4 (25)1 (06)2 (13)5 (20)15 (14)34 (15)
Dehydration15 (40)4 (25)3 (18)4 (27)9 (36)26 (24)61 (28)
Vomiting29 (76)12 (75)10 (59)9 (60)16 (64)74 (67)150 (68)
Temp >38°C (rectal)7 (18)5 (31)5 (29)2 (13)3 (12)18 (16)40 (18)
Temp (reported) prior to hospital help37 (97)14 (87)16 (94)14 (93)20 (80)94 (85)195 (88)
Mucus in stool20 (53)7 (44)15 (88)c13 (87)d13 (52)73 (66)141 (64)
Mean no. with liquid stools per 24 h7.4 ± 3.75.6 ± 2.76.1 ± 3.76.7 ± 3.37.0 ± 3.45.6 ± 3.26.2 ± 3.5
  • a Others include CS1, CS1 plus CS3, CS2 plus CS3, CS3, CS4 plus CS6, CS5, CS7, CS8, CS12, and CS17.

  • b CF was undetected with a panel of 12 monoclonal antibodies to CFA/I, CS1 to CS8, CS12, CS14, and CS17.

  • c P = 0.011 (CFA/I) and P = 0.003 (CS5 plus CS6).

  • d P = 0.021 (CFA/I) and P = 0.013 (CS5 plus CS6).